SEBA Networking Lunches
SEBA's networking lunch series brings together students and professionals for happy hour.
Learn about the day to day work of a particular career, pros/cons of specific disciplines, and how to prepare for working in a particular industry.
Before attending an event, participants are asked to submit an updated resume and online application. For more information, email firstname.lastname@example.org
Read About Our Past Speakers
May 19, 2022
Matthias is a technologist and entrepreneur with substantial research and development experience. He has founded multiple companies focused on disruptive software technologies and understanding complex systems. He’s an expert in graph databases, relational machine learning, and big data analysis in general! He is the inventor of the Titan graph database and a founder of Aurelius.
April 20, 2022
David Youssefina is an organizational psychologist, founder (X), and advisor. After a successful consulting career (Mercer, Critical Metrics), he made the transition to early-stage technology and co-founded his first VC-backed technology company (Uplevel, backed by Norwest, Madrona, and others). David is now focused on solving some of the pressing issues with remote work, specifically, the increase in burnout, isolation, and silos. David holds a Ph.D. in Industrial-Organizational Psychology from the City University of New York. When he's not geeking out on organizational science and technology, you can find him tinkering around in a kitchen (past projects include homemade pastrami and smoked trout).
March 4, 2022
Dale Willard is a serial entrepreneur and PhD chemist with over 20 years of business strategy and expertise in the life sciences. He has built companies, raised capital, launched products, created strategic partnerships, and monetized IP portfolios. He's also an active review panelist for the NIH and other agencies and journals. He is currently with the Life Science Washington team, where he mentors startups.
May 3, 2021
Dr. Katherine Wozniak earned her B.S. in Biochemistry with minors in Mathematics and African Studies from Duquesne University in 2014. During her summers as undergrad, she conducted research at the Centers for Disease Control and Prevention in Atlanta, GA. In 2019, Dr. Wozniak earned her Ph.D. from the University of Pittsburgh in Molecular, Cellular, and Developmental Biology with a minor in Teaching. She studied reproduction in aquatic organisms under the guidance of Dr. Anne Carlson; specifically, Katie focused on investigating the electrical events that occur at the moment of fertilization. Katie is currently a Postdoctoral Researcher at the Los Alamos National Laboratory in New Mexico working within the Agile Biofoundry to synthetically engineer microbial hosts to produce industrially relevant bioproducts.
Apr. 15, 2021
Jeff is currently a Senior Strategic Account Manager for Synthego Corporation, the genome engineering innovation company. Synthego's genome engineering platforms enable broader access to CRISPR to accelerate basic scientific discovery, uncover cures for diseases, and support the development of cell and gene therapies. He received a PhD in Bioengineering from the UW, where he was also actively involved with SEBA, serving in multiple leadership roles including president.
Apr. 1, 2021
Farah Ali is Co-Founder of FreightWeb, a VC backed startup focused on innovation in hardware and software solutions that drive profitability and efficiency for transportation companies. She is also an Advisor at Embedded Ventures a new kind of VC Fund, Co-Founder & President One Good Act, Co-Founder and Advisor Pakistani Women in Computing. She is passionate about diversity in the workplace and is a champion for inclusive practices. team! Click here to add images, text and links, or connect data from your collection.
Mar. 3, 2021
Dr. Liachko is the founder and CEO/CSO of Phase Genomics and one of the inventors of their core technology, applying proximity ligation tools to genomics and metagenomics. He received his B.S. at Brandeis University in 2001, his Ph.D. at Cornell in 2007, and went on to do his postdoctoral work in the Department of Genome Sciences at the University of Washington in Seattle. He founded Phase Genomics in 2015 and leads the organization in an executive as well as technical roles.
Mar. 9, 2021
Tesse Rasmussen, PE, has spent 20+ years concentrating on improving transportation options in Los Angeles and around the United States. As a transportation planner and engineer with experience in all stages of project development, Tesse bridges the gap between conceptual planning and detailed design, bringing her expertise in delivery development, financial planning, policy analysis, alternatives comparisons, and environmental regulations. Beginning with her early involvement on several LA Metro transit projects.
Feb. 25, 2021
Aquagga is a lean hardware startup that seeks to end water contamination from toxic "forever chemicals," also known as PFAS. Their patented systems provide end-of-life destruction of remediation byproducts and PFAS-rich wastes for environmental engineering firms, environmental site managers, and solid waste managers. Aquagga was recently accepted to the inaugural cohort of the Tacoma Maritime Blue Incubator, which will provide them with lab and office space to support their first pilot system deployment in late 2021.
Jan. 21, 2021
Sarah has held a variety of business development and managerial roles since completing her MBA at Harvard Business School. While at Amazon she was the Senior Merchandising Manager for Amazon Video, the Head of Engagement Marketing at Prime Video, the HEad of Customer Lifecycle and Programming, and the Head of Social at Prime Video. Now VP of Business and Corporate Development at Leafly, she drives partnerships and strategic initiatives for the world's largest online cannabis destination.
Jan. 14, 2021
Dan Millman joined the Allen Institute in 2016 as a member of the Neural Coding group. His research focuses on the coding of sensory information in visual cortex during ethologically-relevant behavior, including the influence of non-visual inputs on the representation of visual information Prior to starting a PhD, he completed a master’s thesis in Neuroscience at Johns Hopkins University in the lab of Ernst Niebur. In that work, he used computational methods, including modeling and large-scale network simulations, to study the spatiotemporal dynamics of population activity in recurrent neuronal networks.
Dr. Amber Ismael
Dec. 1, 2020
Dr. Amber Ismael manages the Office of Scientific Career Development at the Fred Hutchinson Cancer Research Center. She earned her PhD in Biology and leverages her experiences as a graduate student and a postdoctoral scholar to assist the next generation of scientists in achieving their career goals by providing career guidance and professional development. Out in the wild, you may find Amber exploring the Pacific Northwest, hiking, trail running, cross country skiing, or trying to make the perfect pizza.
Nov. 17, 2020
Robert A. White is a nationally recognized minority veteran leader experienced in building networks and teams, strategic and economic development, public policies, and veteran and racial equity initiatives. After a 20+ year military career, he served as the CEO for VETTED Foundation and recently as the Director of Community Impact for Minority Veterans of America (MVA). He holds an Executive Master of Public Administration degree from the Evans School, University of Washington.
Nov. 5, 2020
Chris Metcalfe is president and co-founder of Korvata Inc., which he co-founded while he was a graduate student at the Foster School of Business. Prior to that he co-founded a data analytics startup Versive (acquired by eSentire), and served as an associate at Atlas Venture and a senior product marketing manager at Isilon Systems (now part of Dell EMC). Chris holds bachelor degrees in economics and computer science from UPENN, a Masters in Media Technology from the MIT Media Lab, and an MBA from the University of Washington.
Oct. 210, 2020
Dr. Vissinga is inspired by the immune system and how it can be manipulated and provide tools to combat grievous illnesses and improve the lives of patients. Her focus is the discovery and development of novel immune therapeutics. As a Ph.D. immunologist she has worked in both academic and biotech settings in positions with increasing responsibility and complexity.